Loading…
Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement
Systemic sclerosis (SSc) is a chronic, multisystemic, autoimmune disease characterised by vascular changes and varying degrees of fibrosis of the skin and visceral organs. Organ systemic involvement in SSc is associated with an altered function of endothelial cells, perivascular infiltrating mononuc...
Saved in:
Published in: | Clinical rheumatology 2005-04, Vol.24 (2), p.111-116 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c326t-b5967d0e404cb7da13556c1750e9dd093961e7d151a41c886ffed88f8aa9a4f63 |
---|---|
cites | cdi_FETCH-LOGICAL-c326t-b5967d0e404cb7da13556c1750e9dd093961e7d151a41c886ffed88f8aa9a4f63 |
container_end_page | 116 |
container_issue | 2 |
container_start_page | 111 |
container_title | Clinical rheumatology |
container_volume | 24 |
creator | Kuryliszyn-Moskal, Anna Klimiuk, Piotr Adrian Sierakowski, Stanislaw |
description | Systemic sclerosis (SSc) is a chronic, multisystemic, autoimmune disease characterised by vascular changes and varying degrees of fibrosis of the skin and visceral organs. Organ systemic involvement in SSc is associated with an altered function of endothelial cells, perivascular infiltrating mononuclear cells and interstitial fibrosis. To evaluate the relationship between systemic manifestations and immunological markers of endothelial cell activation, serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 (ET-1) were determined by an enzyme-linked immunosorbent assay in 31 SSc patients and in 30 healthy controls. In comparison with the control group, higher serum concentrations of sVCAM-1, sE-selectin, VEGF and ET-1 were detected in SSc patients (in all cases p |
doi_str_mv | 10.1007/s10067-004-0987-3 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67720290</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2418615191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-b5967d0e404cb7da13556c1750e9dd093961e7d151a41c886ffed88f8aa9a4f63</originalsourceid><addsrcrecordid>eNpdkcFqGzEQhpfS0rhpH6CXInooCUStZO2upN6CcdJCSg9tcxXyajZW0EqOZtchD9d3i4wNhlxmYPjmZ4avqj5y9pUzJr9hqa2kjNWUaSWpeFXNeC1qqnWtX1czJiWjgmt1Ur1DvGeMzZXmb6sT3ohaS61m1f8_KUyrAMS6NaBPkQwpQDcFQHKGt4vLX5RfEFxShDIefTy_IFuLBbCZQHRpXEPwNpC7nB7HNeltN6ZMzm6X11fnxEZ3hCLlxEeysaOHOCJ59IXHJxxh8B3BLkBO6PE7yRAKkyKu_YaMiaR8Z-OR9HGbwhaGEvK-etPbgPDh0E-rf1fLv4sf9Ob39c_F5Q3txLwd6arRrXQMalZ3K-ksF03Tdlw2DLRzTAvdcpCON9zWvFOq7XtwSvXKWm3rvhWn1Zd97ianhwlwNIPHDkKwEdKEppVyzuaaFfDzC_A-TTmW24xSXCjB5C6N76GuPIwZerPJfrD5yXBmdmLNXqwpYs1OrBFl59MheFoN4I4bB5PiGY9PoUo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>881383076</pqid></control><display><type>article</type><title>Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement</title><source>Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List</source><creator>Kuryliszyn-Moskal, Anna ; Klimiuk, Piotr Adrian ; Sierakowski, Stanislaw</creator><creatorcontrib>Kuryliszyn-Moskal, Anna ; Klimiuk, Piotr Adrian ; Sierakowski, Stanislaw</creatorcontrib><description>Systemic sclerosis (SSc) is a chronic, multisystemic, autoimmune disease characterised by vascular changes and varying degrees of fibrosis of the skin and visceral organs. Organ systemic involvement in SSc is associated with an altered function of endothelial cells, perivascular infiltrating mononuclear cells and interstitial fibrosis. To evaluate the relationship between systemic manifestations and immunological markers of endothelial cell activation, serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 (ET-1) were determined by an enzyme-linked immunosorbent assay in 31 SSc patients and in 30 healthy controls. In comparison with the control group, higher serum concentrations of sVCAM-1, sE-selectin, VEGF and ET-1 were detected in SSc patients (in all cases p<0.001). Elevated concentrations of sVCAM-1 (p<0.05), sE-selectin (p<0.05), VEGF (p<0.05) and ET-1 (p<0.01) dominated in the serum of SSc patients with organ systemic involvement compared to those without systemic manifestation of the disease. These results suggest that the serum levels of sVCAM-1, sE-selectin, VEGF and ET-1 may reflect the extent of internal organ involvement in SSc patients and point to a pathogenic role of these molecules in systemic manifestation of the disease.</description><identifier>ISSN: 0770-3198</identifier><identifier>EISSN: 1434-9949</identifier><identifier>DOI: 10.1007/s10067-004-0987-3</identifier><identifier>PMID: 15349798</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Biomarkers ; Cell adhesion & migration ; E-Selectin - blood ; Endothelin-1 - blood ; Female ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Proteins ; Scleroderma, Systemic - blood ; Scleroderma, Systemic - physiopathology ; Severity of Illness Index ; Solubility ; Vascular Cell Adhesion Molecule-1 - blood ; Vascular endothelial growth factor ; Vascular Endothelial Growth Factor A - blood</subject><ispartof>Clinical rheumatology, 2005-04, Vol.24 (2), p.111-116</ispartof><rights>Clinical Rheumatology 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c326t-b5967d0e404cb7da13556c1750e9dd093961e7d151a41c886ffed88f8aa9a4f63</citedby><cites>FETCH-LOGICAL-c326t-b5967d0e404cb7da13556c1750e9dd093961e7d151a41c886ffed88f8aa9a4f63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15349798$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kuryliszyn-Moskal, Anna</creatorcontrib><creatorcontrib>Klimiuk, Piotr Adrian</creatorcontrib><creatorcontrib>Sierakowski, Stanislaw</creatorcontrib><title>Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement</title><title>Clinical rheumatology</title><addtitle>Clin Rheumatol</addtitle><description>Systemic sclerosis (SSc) is a chronic, multisystemic, autoimmune disease characterised by vascular changes and varying degrees of fibrosis of the skin and visceral organs. Organ systemic involvement in SSc is associated with an altered function of endothelial cells, perivascular infiltrating mononuclear cells and interstitial fibrosis. To evaluate the relationship between systemic manifestations and immunological markers of endothelial cell activation, serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 (ET-1) were determined by an enzyme-linked immunosorbent assay in 31 SSc patients and in 30 healthy controls. In comparison with the control group, higher serum concentrations of sVCAM-1, sE-selectin, VEGF and ET-1 were detected in SSc patients (in all cases p<0.001). Elevated concentrations of sVCAM-1 (p<0.05), sE-selectin (p<0.05), VEGF (p<0.05) and ET-1 (p<0.01) dominated in the serum of SSc patients with organ systemic involvement compared to those without systemic manifestation of the disease. These results suggest that the serum levels of sVCAM-1, sE-selectin, VEGF and ET-1 may reflect the extent of internal organ involvement in SSc patients and point to a pathogenic role of these molecules in systemic manifestation of the disease.</description><subject>Biomarkers</subject><subject>Cell adhesion & migration</subject><subject>E-Selectin - blood</subject><subject>Endothelin-1 - blood</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Proteins</subject><subject>Scleroderma, Systemic - blood</subject><subject>Scleroderma, Systemic - physiopathology</subject><subject>Severity of Illness Index</subject><subject>Solubility</subject><subject>Vascular Cell Adhesion Molecule-1 - blood</subject><subject>Vascular endothelial growth factor</subject><subject>Vascular Endothelial Growth Factor A - blood</subject><issn>0770-3198</issn><issn>1434-9949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpdkcFqGzEQhpfS0rhpH6CXInooCUStZO2upN6CcdJCSg9tcxXyajZW0EqOZtchD9d3i4wNhlxmYPjmZ4avqj5y9pUzJr9hqa2kjNWUaSWpeFXNeC1qqnWtX1czJiWjgmt1Ur1DvGeMzZXmb6sT3ohaS61m1f8_KUyrAMS6NaBPkQwpQDcFQHKGt4vLX5RfEFxShDIefTy_IFuLBbCZQHRpXEPwNpC7nB7HNeltN6ZMzm6X11fnxEZ3hCLlxEeysaOHOCJ59IXHJxxh8B3BLkBO6PE7yRAKkyKu_YaMiaR8Z-OR9HGbwhaGEvK-etPbgPDh0E-rf1fLv4sf9Ob39c_F5Q3txLwd6arRrXQMalZ3K-ksF03Tdlw2DLRzTAvdcpCON9zWvFOq7XtwSvXKWm3rvhWn1Zd97ianhwlwNIPHDkKwEdKEppVyzuaaFfDzC_A-TTmW24xSXCjB5C6N76GuPIwZerPJfrD5yXBmdmLNXqwpYs1OrBFl59MheFoN4I4bB5PiGY9PoUo</recordid><startdate>200504</startdate><enddate>200504</enddate><creator>Kuryliszyn-Moskal, Anna</creator><creator>Klimiuk, Piotr Adrian</creator><creator>Sierakowski, Stanislaw</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>200504</creationdate><title>Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement</title><author>Kuryliszyn-Moskal, Anna ; Klimiuk, Piotr Adrian ; Sierakowski, Stanislaw</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-b5967d0e404cb7da13556c1750e9dd093961e7d151a41c886ffed88f8aa9a4f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Biomarkers</topic><topic>Cell adhesion & migration</topic><topic>E-Selectin - blood</topic><topic>Endothelin-1 - blood</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Proteins</topic><topic>Scleroderma, Systemic - blood</topic><topic>Scleroderma, Systemic - physiopathology</topic><topic>Severity of Illness Index</topic><topic>Solubility</topic><topic>Vascular Cell Adhesion Molecule-1 - blood</topic><topic>Vascular endothelial growth factor</topic><topic>Vascular Endothelial Growth Factor A - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kuryliszyn-Moskal, Anna</creatorcontrib><creatorcontrib>Klimiuk, Piotr Adrian</creatorcontrib><creatorcontrib>Sierakowski, Stanislaw</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kuryliszyn-Moskal, Anna</au><au>Klimiuk, Piotr Adrian</au><au>Sierakowski, Stanislaw</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement</atitle><jtitle>Clinical rheumatology</jtitle><addtitle>Clin Rheumatol</addtitle><date>2005-04</date><risdate>2005</risdate><volume>24</volume><issue>2</issue><spage>111</spage><epage>116</epage><pages>111-116</pages><issn>0770-3198</issn><eissn>1434-9949</eissn><abstract>Systemic sclerosis (SSc) is a chronic, multisystemic, autoimmune disease characterised by vascular changes and varying degrees of fibrosis of the skin and visceral organs. Organ systemic involvement in SSc is associated with an altered function of endothelial cells, perivascular infiltrating mononuclear cells and interstitial fibrosis. To evaluate the relationship between systemic manifestations and immunological markers of endothelial cell activation, serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 (ET-1) were determined by an enzyme-linked immunosorbent assay in 31 SSc patients and in 30 healthy controls. In comparison with the control group, higher serum concentrations of sVCAM-1, sE-selectin, VEGF and ET-1 were detected in SSc patients (in all cases p<0.001). Elevated concentrations of sVCAM-1 (p<0.05), sE-selectin (p<0.05), VEGF (p<0.05) and ET-1 (p<0.01) dominated in the serum of SSc patients with organ systemic involvement compared to those without systemic manifestation of the disease. These results suggest that the serum levels of sVCAM-1, sE-selectin, VEGF and ET-1 may reflect the extent of internal organ involvement in SSc patients and point to a pathogenic role of these molecules in systemic manifestation of the disease.</abstract><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>15349798</pmid><doi>10.1007/s10067-004-0987-3</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0770-3198 |
ispartof | Clinical rheumatology, 2005-04, Vol.24 (2), p.111-116 |
issn | 0770-3198 1434-9949 |
language | eng |
recordid | cdi_proquest_miscellaneous_67720290 |
source | Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List |
subjects | Biomarkers Cell adhesion & migration E-Selectin - blood Endothelin-1 - blood Female Humans Male Middle Aged Predictive Value of Tests Proteins Scleroderma, Systemic - blood Scleroderma, Systemic - physiopathology Severity of Illness Index Solubility Vascular Cell Adhesion Molecule-1 - blood Vascular endothelial growth factor Vascular Endothelial Growth Factor A - blood |
title | Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T08%3A24%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Soluble%20adhesion%20molecules%20(sVCAM-1,%20sE-selectin),%20vascular%20endothelial%20growth%20factor%20(VEGF)%20and%20endothelin-1%20in%20patients%20with%20systemic%20sclerosis:%20relationship%20to%20organ%20systemic%20involvement&rft.jtitle=Clinical%20rheumatology&rft.au=Kuryliszyn-Moskal,%20Anna&rft.date=2005-04&rft.volume=24&rft.issue=2&rft.spage=111&rft.epage=116&rft.pages=111-116&rft.issn=0770-3198&rft.eissn=1434-9949&rft_id=info:doi/10.1007/s10067-004-0987-3&rft_dat=%3Cproquest_cross%3E2418615191%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c326t-b5967d0e404cb7da13556c1750e9dd093961e7d151a41c886ffed88f8aa9a4f63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=881383076&rft_id=info:pmid/15349798&rfr_iscdi=true |